ACHFF (Arch Biopartners) Cyclically Adjusted PB Ratio: (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ACHFF Arch Biopartners Inc ACHFF
22 GF Score
Price $0.60
! 4 Warning Signs
View Full Analysis

What is Arch Biopartners Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Arch Biopartners  (OTCPK:ACHFF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Arch Biopartners Cyclically Adjusted PB Ratio Related Terms


Arch Biopartners Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Arch Biopartners's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arch Biopartners Cyclically Adjusted PB Ratio Chart

Arch Biopartners Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Arch Biopartners Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ACHFF vs VRTX, REGN, ALNY: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, Arch Biopartners's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arch Biopartners Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Biopartners's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Arch Biopartners's Cyclically Adjusted PB Ratio falls into.


ACHFF
22GF Score
Arch Biopartners Inc ACHFF
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arch Biopartners Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Arch Biopartners's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Arch Biopartners's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.039/132.2623*132.2623
=-0.039

Current CPI (Mar. 2026) = 132.2623.

Arch Biopartners Quarterly Data

Book Value per Share CPI Adj_Book
201606 -0.001 102.002 -0.001
201609 -0.004 101.765 -0.005
201612 -0.007 101.449 -0.009
201703 -0.003 102.634 -0.004
201706 -0.007 103.029 -0.009
201709 -0.008 103.345 -0.010
201712 -0.013 103.345 -0.017
201803 -0.003 105.004 -0.004
201806 -0.004 105.557 -0.005
201809 -0.011 105.636 -0.014
201812 -0.023 105.399 -0.029
201903 -0.029 106.979 -0.036
201906 -0.029 107.690 -0.036
201909 -0.034 107.611 -0.042
201912 -0.045 107.769 -0.055
202003 -0.041 107.927 -0.050
202006 -0.032 108.401 -0.039
202009 -0.048 108.164 -0.059
202012 -0.061 108.559 -0.074
202103 -0.074 110.298 -0.089
202106 -0.064 111.720 -0.076
202109 -0.049 112.905 -0.057
202112 -0.051 113.774 -0.059
202203 -0.050 117.646 -0.056
202206 -0.050 120.806 -0.055
202209 -0.054 120.648 -0.059
202212 -0.053 120.964 -0.058
202303 -0.064 122.702 -0.069
202306 -0.069 124.203 -0.073
202309 -0.065 125.230 -0.069
202312 -0.068 125.072 -0.072
202403 -0.076 126.258 -0.080
202406 -0.074 127.522 -0.077
202409 -0.050 127.285 -0.052
202412 -0.046 127.364 -0.048
202503 -0.040 129.181 -0.041
202506 -0.040 129.892 -0.041
202509 -0.042 130.287 -0.043
202512 -0.039 130.366 -0.040
202603 -0.039 132.262 -0.039

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Arch Biopartners Business Description

Other Exchanges 8HA:GermanyARCH:Canada
Address 545 King Street West, Toronto, ON, CAN, M5V 1M1
Arch Biopartners Inc is a developer of a therapeutic pipeline designed to address acute kidney injury (AKI) and chronic kidney disease (CKD) by targeting inflammation- and toxin-related kidney damage. The group offers mechanism-based treatments, enabling patients suffering from both acute and chronic kidney conditions to benefit from novel, targeted therapies that address unmet medical needs in kidney care.
22GF Score

Get the complete analysis for ACHFF

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.60
Price